Global Vaccine Partnering Terms and Agreements 2010-2016: Comprehensive Access to Available Deals and Contract Documents for Over 880 Vaccine Deals

Mar 17, 2016, 13:10 ET from Research and Markets

DUBLIN, March 17, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vfhqx9/global_vaccine) has announced the addition of the "Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials" report to their offering.

The Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

This report contains a comprehensive listing of all vaccine partnering deals announced since January 2010, including financial terms where available, including over 1,000 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The report takes readers through the vaccine deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering vaccine partnering deals.

The report presents average financial deal terms values for vaccine deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In Global Vaccine Partnering Terms and Agreements 2010-2016: Deal trends, players and financials, the available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Therapy target
  • Specific technology type

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Vaccines dealmaking

Chapter 3 - Leading Vaccines deals

Chapter 4 - Most active Vaccines dealmakers

Chapter 5 - Vaccines contracts dealmaking directory

Chapter 6 - Vaccines dealmaking by technology type

Chapter 7 - Partnering resource center

For more information visit http://www.researchandmarkets.com/research/vfhqx9/global_vaccine

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com